Clinical Trials Logo
  1. Home
  2. Head & Neck Cancer
  3. NCT00935961

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

HEAD & NECK Cancer Clinical Trial

Official title:
A Phase I Study of RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

Clinical Trial Summary

The purpose of this study is to test the safety of RAD001 (everolimus) tablets at different dose levels, when added to docetaxel and cisplatin. The investigators want to find out what effects, good and/or bad, that everolimus has when added to docetaxel and cisplatin as treatment for head and neck cancer.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00935961
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact
Status Completed
Phase Phase 1
Start date July 2009
Completion date August 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT00670553 - A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer Phase 1
Completed NCT03799380 - DRIHNC - Dehydration Reduction in Head & Neck Cancer N/A
Completed NCT03157674 - Real-World Evidence and Treatment Patterns: Head and Neck Cancer
Completed NCT00565721 - A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis Phase 2
Completed NCT00796952 - Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients Phase 2
Recruiting NCT03065062 - Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors Phase 1
Completed NCT01268579 - Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma N/A
Completed NCT03712397 - Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy Phase 2
Completed NCT04040166 - Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy N/A
Completed NCT00736619 - Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) Phase 1
Completed NCT02375958 - PCA062 in pCAD-positive Tumors. Phase 1